Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Jack Russell who wrote (12156)	7/2/2013 8:11:23 AM
From: NTTG	1 Recommendation Recommended By Pogeu Mahone Read Replies (1) \| Respond to of 13111

Obviously by next years meeting the company will be well underway to AA for MM (by-passing their PIII requirements through BTD approval), a regional deal for HCC will have been signed with up front and first milestone payments in the bank, a significant psoriasis partner for PH-10 will have been secured, the breast cancer development program will be revived and heading into PII trials, the pancreatic cancer initiative will be well underway, the antibacterial properties of RB will be under intense investigation for ABSSSI, PVCT will be trading on NASDAQ, and the company will be buying back shares at a fevered rate. I would hate to think that with all that good news, my concerns over the popcorn they plan to serve would impact my decision to attend.